ATC Group: S02AA16 Ofloxacin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of S02AA16 in the ATC hierarchy

Level Code Title
1 S Sensory organs
2 S02 Otologicals
3 S02A Antiinfectives
4 S02AA Antiinfectives
5 S02AA16

Active ingredients in S02AA16

Active Ingredient

Ofloxacin is a quinolone-carboxylic acid derivative with a wide range of antibacterial activity against both Gram-negative and Gram-positive organisms. The primary mode of action of the quinolones is the specific inhibition of bacterial DNA gyrase. This enzyme is required for DNA replication, transcription, repair and recombination.

Related product monographs

Document Type Information Source  
 TARIVID Solution for infusion MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicines in this ATC group

Austria (AT)

Estonia (EE)

France (FR)

Hong Kong (HK)

Ireland (IE)

Japan (JP)

Malta (MT)

Netherlands (NL)

Nigeria (NG)

Poland (PL)

Singapore (SG)

Tunisia (TN)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.